Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
25.64+0.10 (+0.39%)
At close: 04:00PM EDT
25.64 0.00 (0.00%)
After hours: 04:49PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close25.54
Open25.77
Bid24.78 x 4000
Ask27.80 x 900
Day's Range25.60 - 26.45
52 Week Range15.83 - 29.93
Volume1,102,862
Avg. Volume613,442
Market Cap2.96B
Beta (5Y Monthly)0.43
PE Ratio (TTM)30.16
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Zacks

    Corcept (CORT) Up More Than 20% in Past 3 Months: Here's Why

    Corcept's (CORT) Cushing's syndrome drug, Korlym, is witnessing higher sales and a strong uptake since its approval. Other pipeline candidates are also advancing well.

  • Motley Fool

    2 Top Biotech Stocks Defying the Bear Market

    Thanks to the Federal Reserve's mission to control inflation by hiking interest rates, investor sentiment for companies that might need to borrow money is incredibly poor -- and that makes biotech stocks an even riskier investment than usual. Axsome Therapeutics (NASDAQ: AXSM) is up by more than 127% in the last 12 months, and there might be another growth spurt in the works. This year, it went from having zero products on the market to having two: Sunosi for narcolepsy and Auvelity for major depressive disorder (MDD).

  • Motley Fool

    2 Growth Stocks That Are Beating Amazon Without Breaking a Sweat

    Big technology companies aren't always the portfolio winners that they're cracked up to be. Down by 28% over the past 12 months, shares of Amazon (NASDAQ: AMZN) are performing even worse than the market's decline of 13% in the same period. Jazz Pharmaceuticals (NASDAQ: JAZZ) is up 14.6% in the last 12 months, and the drugmaker is beating Amazon because its portfolio of medications on the market will be ramping up sales in the near future.

Advertisement
Advertisement